semaglutide after breast cancer GLP-1 medications may improve survival and reduce recurrence in patients, study finds. More details in comments GLP-1s appear to cut cancer
Description
Some people report feeling nothing at all, particularly on their second and third injections once injection anxiety decreases
Gilmartin-Thomas JF, Liew D, Hopper I
Quality & Compliance Every batch of retatrutide is produced to exacting laboratory standards
Doses were titrated upward every 2 weeks to a goal of sitagliptin/metformin 50/1,000 mg twice daily or metformin 1,000 mg twice daily
